MOv18 IgE

MOv18 IgE · Epsilogen Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MOv18 IgE, covering 2023-06-05 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha [Phase 1]